at long last some good

news.
Despite the shi*&%&house mangt., these guys finally may succeed despite themselves.
To all of the very patient AVT holders, a small AFR article on Monday with a Hunter Hall investment manager talking about AVT's chinese blood fractionation plants and agreements.
The market capitalisation, currently sub $50m has the potential he believed to be in excess of $750m. Still about 12 months for plant completion and logistics to be finalised, BUT DEFINITELY warrants a place on the bottom of the draw he felt! And HHall have a great stockpicking record.